In this episode of The BioHub by Avetix, I'm joined by Valerie Vanhooren, CEO and Co-Founder of Ona Therapeutics.


Recorded shortly after Ona Therapeutics announced its $85 million Series B, Valerie shares the journey behind building the company, the challenges of fundraising in today's biotech market, and the opportunity to develop next-generation precision oncology therapies that improve outcomes for patients with cancer.


We also discuss the evolution of antibody-drug conjugates (ADCs), what it takes to build a biotech from the ground up, the importance of company culture, and Valerie's vision for the future of precision oncology.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Max Brennan - Biotech HeadHunter. Innehållet i podden är skapat av Max Brennan - Biotech HeadHunter och inte av, eller tillsammans med, Poddtoppen.